Literature DB >> 33058782

Tetracycline Antibiotics Induce Host-Dependent Disease Tolerance to Infection.

Henrique G Colaço1, André Barros1, Ana Neves-Costa1, Elsa Seixas1, Dora Pedroso1, Tiago Velho1, Katharina L Willmann1, Pedro Faisca1, Gerlinde Grabmann2, Hyon-Seung Yi3, Minho Shong3, Vladimir Benes4, Sebastian Weis5, Thomas Köcher2, Luís F Moita6.   

Abstract

Several classes of antibiotics have long been known to have beneficial effects that cannot be explained strictly on the basis of their capacity to control the infectious agent. Here, we report that tetracycline antibiotics, which target the mitoribosome, protected against sepsis without affecting the pathogen load. Mechanistically, we found that mitochondrial inhibition of protein synthesis perturbed the electron transport chain (ETC) decreasing tissue damage in the lung and increasing fatty acid oxidation and glucocorticoid sensitivity in the liver. Using a liver-specific partial and acute deletion of Crif1, a critical mitoribosomal component for protein synthesis, we found that mice were protected against sepsis, an observation that was phenocopied by the transient inhibition of complex I of the ETC by phenformin. Together, we demonstrate that mitoribosome-targeting antibiotics are beneficial beyond their antibacterial activity and that mitochondrial protein synthesis inhibition leading to ETC perturbation is a mechanism for the induction of disease tolerance.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  disease tolerance; doxycycline; electron transport chain; immunometabolism; liver; lung; mitochondria; mitoribosome; sepsis

Year:  2020        PMID: 33058782     DOI: 10.1016/j.immuni.2020.09.011

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  10 in total

1.  Antibiotic-induced disease tolerance.

Authors:  Kirsty Minton
Journal:  Nat Rev Immunol       Date:  2020-12       Impact factor: 53.106

Review 2.  Mitochondrial ribosomal stress in lung diseases.

Authors:  Loukmane Karim; Beata Kosmider; Karim Bahmed
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-12-07       Impact factor: 5.464

3.  Type I interferon regulates proteolysis by macrophages to prevent immunopathology following viral infection.

Authors:  Amanda J Lee; Emily Feng; Marianne V Chew; Elizabeth Balint; Sophie M Poznanski; Elizabeth Giles; Ali Zhang; Art Marzok; Spencer D Revill; Fatemeh Vahedi; Anisha Dubey; Ehab Ayaub; Rodrigo Jimenez-Saiz; Joshua J C McGrath; Tyrah M Ritchie; Manel Jordana; Danny D Jonigk; Maximilian Ackermann; Kjetil Ask; Matthew Miller; Carl D Richards; Ali A Ashkar
Journal:  PLoS Pathog       Date:  2022-05-05       Impact factor: 7.464

Review 4.  Mechanisms of Post-critical Illness Cardiovascular Disease.

Authors:  Andrew Owen; Jaimin M Patel; Dhruv Parekh; Mansoor N Bangash
Journal:  Front Cardiovasc Med       Date:  2022-07-15

5.  Common methods in mitochondrial research (Review).

Authors:  Yiyuan Yin; Haitao Shen
Journal:  Int J Mol Med       Date:  2022-08-25       Impact factor: 5.314

6.  Tetracycline-induced mitohormesis mediates disease tolerance against influenza.

Authors:  Adrienne Mottis; Terytty Y Li; Gaby El Alam; Alexis Rapin; Elena Katsyuba; David Liaskos; Davide D'Amico; Nicola L Harris; Mark C Grier; Laurent Mouchiroud; Mark L Nelson; Johan Auwerx
Journal:  J Clin Invest       Date:  2022-09-01       Impact factor: 19.456

7.  Tetracyclines: four rings to rule infections through resistance and disease tolerance.

Authors:  Kátia Jesus; Luís F Moita
Journal:  J Clin Invest       Date:  2022-09-01       Impact factor: 19.456

Review 8.  Multifunctions of CRIF1 in cancers and mitochondrial dysfunction.

Authors:  Yangzhou Jiang; Yang Xiang; Chuanchuan Lin; Weiwei Zhang; Zhenxing Yang; Lixin Xiang; Yanni Xiao; Li Chen; Qian Ran; Zhongjun Li
Journal:  Front Oncol       Date:  2022-10-03       Impact factor: 5.738

9.  Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15.

Authors:  Irene Cimino; Hanna Kim; Y C Loraine Tung; Kent Pedersen; Debra Rimmington; John A Tadross; Sara N Kohnke; Ana Neves-Costa; André Barros; Stephanie Joaquim; Don Bennett; Audrey Melvin; Samuel M Lockhart; Anthony J Rostron; Jonathan Scott; Hui Liu; Keith Burling; Peter Barker; Menna R Clatworthy; E-Chiang Lee; A John Simpson; Giles S H Yeo; Luís F Moita; Kendra K Bence; Sebastian Beck Jørgensen; Anthony P Coll; Danna M Breen; Stephen O'Rahilly
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-06       Impact factor: 12.779

Review 10.  Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?

Authors:  Andrea Sauer; Christian Putensen; Christian Bode
Journal:  Crit Care       Date:  2022-03-22       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.